ArticleBioengineering (Basel, Switzerland)2026
A Single-Wavelength Near-Infrared Photoacoustic Spectroscopy for Noninvasive Glucose Detection Using Machine Learning.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
According to the International Diabetes Federation, 589 million adults worldwide live with diabetes in 2025 (approximately 1 in 9 adults). The development of convenient noninvasive blood glucose monitoring systems has been a central focus in diabetes management. Optical spectroscopy has advanced significantly among all noninvasive glucose detection techniques. A photoacoustic system has been developed using a single-wavelength near-infrared laser, operating at 1625 nm, where glucose exhibits an overtone absorption band with relatively low water interference. The noninvasive system has been evaluated using artificial skin phantoms, with different glucose concentrations, covering both normoglycemic and hyperglycemic blood glucose levels. The detection sensitivity of the developed system has been enhanced to ±15 mg/dL across the entire clinically relevant glucose range. K-nearest neighbours and wide neural network machine learning models were developed for noninvasive glucose classification. The models achieved prediction accuracies of 80.0% and 81.5%, respectively, with 100% of the predicted data located within zones A and B of Clarke's error grid analysis. These findings satisfy the regulatory requirements for glucose monitors established by Health Canada and the U.S. Food and Drug Administration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.